Glenn Frank Short is Chief Scientific Officer at ATAI Life Sciences N.V. (ATAI). They have made 1 open-market trade across 1 company since 2025, most recently 2025-03-21.
CIK 0002049070
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ATAI | 42,333 | $311K |
Shares reported on the most recent Form 4, priced at the 2025-03-24 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ATAI | SELL | 2025-03-21 | 2025-03-24 | $1.35 | $18K | -20.8% | -8.4% | +21.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.